ok_老虎社区_美港股上老虎

Bulacan
2021-06-29

Dump FAANG and Buy These 3 Cheaper Growth Stocks Instead

These investments offer investors a good mix of value and growth.

Dump FAANG and Buy These 3 Cheaper Growth Stocks Instead

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":159416313,"tweetId":"159416313","gmtCreate":1624976683632,"gmtModify":1631893061560,"author":{"id":3585795690900312,"idStr":"3585795690900312","authorId":3585795690900312,"authorIdStr":"3585795690900312","name":"Bulacan","avatar":"https://static.tigerbbs.com/8073bf36630ac72a8b822fb562f1dc63","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":6,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>ok</p></body></html>","htmlText":"<html><head></head><body><p>ok</p></body></html>","text":"ok","highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/159416313","repostId":2147802868,"repostType":4,"repost":{"id":"2147802868","pubTimestamp":1624976437,"share":"https://www.laohu8.com/m/news/2147802868?lang=&edition=full","pubTime":"2021-06-29 22:20","market":"us","language":"en","title":"Dump FAANG and Buy These 3 Cheaper Growth Stocks Instead","url":"https://stock-news.laohu8.com/highlight/detail?id=2147802868","media":"Motley Fool","summary":"These investments offer investors a good mix of value and growth.","content":"<p>Buying shares of top tech stocks <b><a href=\"https://laohu8.com/S/FB\">Facebook</a></b>, <b>Apple</b>, <b>Amazon</b>, <b>Netflix</b>, and <b>Alphabet</b> (Google) -- otherwise known as FAANG -- would have earned great returns in the past. But now, with their valuations creeping up and the cheapest of those stocks (Apple and Facebook) trading at a forward price-to-earnings (P/E) multiple of more than 26, they aren't as promising when compared to other growth stocks.</p>\n<p>If you are looking to make the most of your investment dollars, you should consider buying shares of <b>Pfizer </b>(NYSE:PFE), <b>Oracle </b>(NYSE:ORCL), and <b>UPS </b>(NYSE:UPS) instead of FAANG. They have strong, growing businesses and they are much cheaper buys.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d09d93a3202374ea6de8f4a93b9ae1a2\" tg-width=\"700\" tg-height=\"466\"><span>Image source: Getty Images.</span></p>\n<h2>1. Pfizer</h2>\n<p>Healthcare giant Pfizer is trading at just 10 times its future earnings. The company has lately become smaller but more growth-oriented after the November 2020 spinoff of its Upjohn business with <b>Mylan</b> to form what is now <b>Viatris</b>. That said, Upjohn wasn't a significant growth driver for Pfizer. In the most recent full quarter during which it was part of Pfizer's business, for the period ending Sept. 27, its quarterly revenue of $1.9 billion was down 19% year over year. By comparison, its biopharmaceutical segment, which will remain part of its operations, generated over $10 billion in sales and was up 3% from the prior-year period.</p>\n<p>And thanks to its COVID-19 vaccine, Pfizer is on track for a stellar year. The company projects that it will generate $26 billion in sales from its vaccine this year, and its top line should come in between $70.5 billion and $72.5 billion. In 2020, its sales were just under $42 billion.</p>\n<p>While investors may be concerned that vaccine sales will be short-lived, the World Health Organization believes people may require booster shots on an annual basis -- especially the most vulnerable. And to make that even easier, Pfizer is also working on an oral drug for COVID-19 that people can take at home. If all goes well in trials, it could be ready before the end of this year.</p>\n<p>Between the strong vaccine sales and Pfizer focusing on developing new drugs and being a leaner organization, the company has become a much more attractive growth stock, and it is a bargain compared to what you would be getting by investing in FAANG.</p>\n<h2>2. Oracle</h2>\n<p>Not all tech stocks are overpriced, and Oracle is a great example of that. At a forward P/E of 17, it's pricier than Pfizer but still a cheaper buy than any of the FAANG stocks. The company offers businesses an array of cloud-based computing solutions, including networking, analytics, storage, and application development.</p>\n<p>When Oracle released its fourth-quarter earnings June 15, both its sales and profits came in above analyst expectations. Revenue of more than $11 billion for the period ending May 31 grew by 8% year over year, while profits totaling $4 billion were up 29%. CEO Safra Catz is bullish on the future of the cloud business, saying that the company is going to double its capital spend on the cloud to nearly $4 billion in the new fiscal year.</p>\n<p>The tech company has enjoyed strong profits with net margins of at least 25% in each of the past three fiscal years. And by making bigger investments in the cloud and looking for ways to add value for businesses that are utilizing more resources online, Oracle could be heading for some terrific growth opportunities. Its modest price tag makes it an even better buy.</p>\n<h2>3. UPS</h2>\n<p>Investing in logistics is another great move if you are seeking out growth. Amid the pandemic, people have been buying more goods online as many stores were closed for in-person shopping. And some of those habits and conveniences are going to be tough to break post-pandemic, especially when a company like Amazon makes it all too easy to order something with just the click of a button. Whether it is Amazon, <b>Etsy</b>, or some other portal, the growth in online shopping and logistics is promising -- estimates from Grand View Research have the third-party logistics market growing at a compound annual rate of 8.5% from now until 2028, when it will reach a value of nearly $1.7 trillion.</p>\n<p>Things have already been off to a great start in 2021, with UPS's revenue of $23 billion for the first three months of this year up an impressive 27% over the same period in 2020. Its operating profit of $2.8 billion was more than double the $1.1 billion it posted a year ago. By 2023, the company projects that it could top $100 billion in revenue. That would be about 18% higher than the $85 billion in sales it posted for 2020.</p>\n<p>UPS trades at a forward P/E of just under 19, making it the priciest stock on this list but still cheaper than investors are paying for FAANG stocks today. With some solid long-term growth ahead, it's still not too late to invest in UPS and take advantage of some strong growth prospects in the logistics industry.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dump FAANG and Buy These 3 Cheaper Growth Stocks Instead</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDump FAANG and Buy These 3 Cheaper Growth Stocks Instead\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-29 22:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/29/dump-faang-and-buy-these-3-cheaper-growth-stocks-i/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Buying shares of top tech stocks Facebook, Apple, Amazon, Netflix, and Alphabet (Google) -- otherwise known as FAANG -- would have earned great returns in the past. But now, with their valuations ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/29/dump-faang-and-buy-these-3-cheaper-growth-stocks-i/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ORCL":"甲骨文","UPS":"联合包裹","PFE":"辉瑞"},"source_url":"https://www.fool.com/investing/2021/06/29/dump-faang-and-buy-these-3-cheaper-growth-stocks-i/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2147802868","content_text":"Buying shares of top tech stocks Facebook, Apple, Amazon, Netflix, and Alphabet (Google) -- otherwise known as FAANG -- would have earned great returns in the past. But now, with their valuations creeping up and the cheapest of those stocks (Apple and Facebook) trading at a forward price-to-earnings (P/E) multiple of more than 26, they aren't as promising when compared to other growth stocks.\nIf you are looking to make the most of your investment dollars, you should consider buying shares of Pfizer (NYSE:PFE), Oracle (NYSE:ORCL), and UPS (NYSE:UPS) instead of FAANG. They have strong, growing businesses and they are much cheaper buys.\nImage source: Getty Images.\n1. Pfizer\nHealthcare giant Pfizer is trading at just 10 times its future earnings. The company has lately become smaller but more growth-oriented after the November 2020 spinoff of its Upjohn business with Mylan to form what is now Viatris. That said, Upjohn wasn't a significant growth driver for Pfizer. In the most recent full quarter during which it was part of Pfizer's business, for the period ending Sept. 27, its quarterly revenue of $1.9 billion was down 19% year over year. By comparison, its biopharmaceutical segment, which will remain part of its operations, generated over $10 billion in sales and was up 3% from the prior-year period.\nAnd thanks to its COVID-19 vaccine, Pfizer is on track for a stellar year. The company projects that it will generate $26 billion in sales from its vaccine this year, and its top line should come in between $70.5 billion and $72.5 billion. In 2020, its sales were just under $42 billion.\nWhile investors may be concerned that vaccine sales will be short-lived, the World Health Organization believes people may require booster shots on an annual basis -- especially the most vulnerable. And to make that even easier, Pfizer is also working on an oral drug for COVID-19 that people can take at home. If all goes well in trials, it could be ready before the end of this year.\nBetween the strong vaccine sales and Pfizer focusing on developing new drugs and being a leaner organization, the company has become a much more attractive growth stock, and it is a bargain compared to what you would be getting by investing in FAANG.\n2. Oracle\nNot all tech stocks are overpriced, and Oracle is a great example of that. At a forward P/E of 17, it's pricier than Pfizer but still a cheaper buy than any of the FAANG stocks. The company offers businesses an array of cloud-based computing solutions, including networking, analytics, storage, and application development.\nWhen Oracle released its fourth-quarter earnings June 15, both its sales and profits came in above analyst expectations. Revenue of more than $11 billion for the period ending May 31 grew by 8% year over year, while profits totaling $4 billion were up 29%. CEO Safra Catz is bullish on the future of the cloud business, saying that the company is going to double its capital spend on the cloud to nearly $4 billion in the new fiscal year.\nThe tech company has enjoyed strong profits with net margins of at least 25% in each of the past three fiscal years. And by making bigger investments in the cloud and looking for ways to add value for businesses that are utilizing more resources online, Oracle could be heading for some terrific growth opportunities. Its modest price tag makes it an even better buy.\n3. UPS\nInvesting in logistics is another great move if you are seeking out growth. Amid the pandemic, people have been buying more goods online as many stores were closed for in-person shopping. And some of those habits and conveniences are going to be tough to break post-pandemic, especially when a company like Amazon makes it all too easy to order something with just the click of a button. Whether it is Amazon, Etsy, or some other portal, the growth in online shopping and logistics is promising -- estimates from Grand View Research have the third-party logistics market growing at a compound annual rate of 8.5% from now until 2028, when it will reach a value of nearly $1.7 trillion.\nThings have already been off to a great start in 2021, with UPS's revenue of $23 billion for the first three months of this year up an impressive 27% over the same period in 2020. Its operating profit of $2.8 billion was more than double the $1.1 billion it posted a year ago. By 2023, the company projects that it could top $100 billion in revenue. That would be about 18% higher than the $85 billion in sales it posted for 2020.\nUPS trades at a forward P/E of just under 19, making it the priciest stock on this list but still cheaper than investors are paying for FAANG stocks today. With some solid long-term growth ahead, it's still not too late to invest in UPS and take advantage of some strong growth prospects in the logistics industry.","news_type":1},"isVote":1,"tweetType":1,"viewCount":140,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":2,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}